SNSE - Sensei Biotherapeutics Inc
29.5
-0.500 -1.695%
Share volume: 165,001
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$30.00
-0.50
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-06-2024 | 11-14-2024 | 03-28-2025 | 05-06-2025 | 11-14-2025 | |
| Assets | |||||||
| Total Assets | 66.695 M | 59.799 M | 53.254 M | 45.361 M | 38.273 M | 27.589 M | |
| Current Assets | 60.234 M | 53.944 M | 48.098 M | 41.929 M | 35.682 M | 25.785 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 269.000 K | 142.000 K | 81.000 K | 120.000 K | 440.000 K | 248.000 K | |
| Short Term Investments | 47.125 M | 40.398 M | 27.870 M | 31.341 M | 24.454 M | 14.479 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 10.956 M | 11.891 M | 19.131 M | 9.994 M | 9.877 M | 10.562 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.065 M | 1.038 M | 899.000 K | 417.000 K | 159.000 K | 112.000 K | |
| Other Assets | 5.396 M | 4.817 M | 4.257 M | 3.015 M | 2.432 M | 1.692 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 66.695 M | 59.799 M | 53.254 M | 45.361 M | 38.273 M | 27.589 M | |
| Total liabilities | 8.221 M | 7.607 M | 7.475 M | 6.975 M | 6.286 M | 4.582 M | |
| Total current liabilities | 4.992 M | 4.949 M | 5.441 M | 5.448 M | 5.229 M | 4.436 M | |
| Accounts Payable | 2.000 M | 1.646 M | 1.676 M | 1.248 M | 2.358 M | 1.405 M | |
| Other liabilities | 2.658 M | 2.281 M | 1.828 M | 1.429 M | 1.022 M | 146.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 2.658 M | 2.281 M | 1.828 M | 1.429 M | 1.022 M | 146.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 58.474 M | 52.192 M | 45.779 M | 38.386 M | 31.987 M | 23.007 M | |
| Common stock | 298.498 M | 299.314 M | 300.047 M | 300.451 M | 300.909 M | 301.431 M | |
| Retained earnings | -239.887 M | -247.029 M | -254.282 M | -262.052 M | -268.916 M | -278.421 M |